kentucky semaglutide gastrointestinal obstruction lawsuit glp-1 attorney Ozempic kentucky semaglutide gi obstruction attorney

Furthermore, the option to continue or initiate new AD medication during the trial, including the amyloid lowering monoclonal antibodies, was not a randomization stratification factor and may therefore act as a confounding factor if their use across treatment arms is unequal

Any changes to your blood pressure medication regimen must be decided by your healthcare provider based on your individual response and repeat blood pressure measurements

Constipation and mild abdominal discomfort also occur in some patients

For example, certain GLP1R variants may inform how your body's GLP-1 signaling pathway responds, potentially supporting your provider's decision between semaglutide's single-receptor activation versus tirzepatide's dual-receptor approach

Slower gallbladder emptying then promotes sludge formation, which can harden into stones

Biosimilars are designed to closely match the reference biologic in terms of safety, efficacy, and quality, following rigorous regulatory pathways and comparability studies